Israeli eye surgery robotics company ForSight Robotics has raised $125 million in a Series B round led by Eclipse. The funding will be used to advance development of the company’s ORYOM platform, a robotic system designed to perform cataract surgery and treat other common eye diseases. The system aims to deliver more precise procedures, expand access to quality care, and reduce the physical burden on surgeons. ForSight’s first human clinical trials are expected to begin this year.
Founded in 2020 by Prof. Moshe Shoham, Dr. Daniel Glozman, and Dr. Joseph Nathan, ForSight is currently headquartered in Yokneam Illit and will soon relocate to Caesarea. The company has raised $195 million to date and employs 110 people in Israel.
Keep reading at calcalistech.com.
ForSight Robotics was co-founded in 2020 by Technion Professor Emeritus Moshe Shoham, Dr. Daniel Glozman, and Technion alumnus Dr. Joseph Nathan, who holds the positions of president and chief medical officer.
More Health & Medicine stories
Wearable Microneedle Patch Offers Real-time Diabetes Tracking
